Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity

  1. Joana B Pereira  Is a corresponding author
  2. Rik Ossenkoppele
  3. Sebastian Palmqvist
  4. Tor Olof Strandberg
  5. Ruben Smith
  6. Eric Westman
  7. Oskar Hansson  Is a corresponding author
  1. Karolinska Institute, Sweden
  2. VU University Medical Center, Netherlands
  3. Lund University, Sweden

Abstract

The abnormal accumulation of amyloid-β and tau targets specific spatial networks in Alzheimer's disease. However, the relationship between these networks across different disease stages and their association with brain connectivity has not been explored. In this study, we applied a joint independent component analysis to 18F- Flutemetamol (amyloid-β) and 18F-Flortaucipir (tau) PET images to identify amyloid-β and tau networks across different stages of Alzheimer's disease. We then assessed whether these patterns were associated with resting-state functional networks and white matter tracts. Our analyses revealed nine patterns that were linked across tau and amyloid-β data. The amyloid-b and tau patterns showed a fair to moderate overlap with distinct functional networks but only tau was associated with white matter integrity loss and multiple cognitive functions. These findings show that amyloid-b and tau have different spatial affinities, which can be used to understand how they accumulate in the brain and potentially damage the brain's connections.

Data availability

Source data files have been provided for Figures 4 and 5. The source data for the rest of the analyses performed in this study can be requested from Prof. Oskar Hansson (Oskar.Hansson@med.lu.se), after signing a material transfer agreement from Lund University that ensures that the data will only be used for the sole purpose of replicating procedures and results presented in the article and as long as data transfer is in agreement with EU legislation on the general data protection regulation and decisions by the Ethical Review Board of Sweden and Region Skåne.

Article and author information

Author details

  1. Joana B Pereira

    Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
    For correspondence
    joana.pereira@ki.se
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4604-2711
  2. Rik Ossenkoppele

    Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  3. Sebastian Palmqvist

    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden
    Competing interests
    No competing interests declared.
  4. Tor Olof Strandberg

    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden
    Competing interests
    No competing interests declared.
  5. Ruben Smith

    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden
    Competing interests
    No competing interests declared.
  6. Eric Westman

    Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  7. Oskar Hansson

    Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden
    For correspondence
    oskar.hansson@med.lu.se
    Competing interests
    Oskar Hansson, has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Biogen, Roche, and Fujirebio.

Funding

European Research Council, Swedish Research Council, Swedish Brain Foundation, Startneuro, Swedish Alzheimer Foundation, Knut and Alice Wallenberg foundation, Strategic Research Area Multipark

  • Oskar Hansson

Swedish Research Council, Alzheimerfonden, Swedish Brain Research

  • Joana B Pereira

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: This study received ethical approval from the Regional Ethical Review Board of Lund University (Dnr 2008-695, 2008-290, 2010-156), the Swedish Medicines and Products Agency (Dnr 151:2012/4552, 5.1-2014-62949), and the Radiation Safety Committee of Skåne University Hospital in Sweden. All participants provided informed consent before being included in the study.

Copyright

© 2019, Pereira et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,534
    views
  • 575
    downloads
  • 69
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Joana B Pereira
  2. Rik Ossenkoppele
  3. Sebastian Palmqvist
  4. Tor Olof Strandberg
  5. Ruben Smith
  6. Eric Westman
  7. Oskar Hansson
(2019)
Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity
eLife 8:e50830.
https://doi.org/10.7554/eLife.50830

Share this article

https://doi.org/10.7554/eLife.50830

Further reading

    1. Neuroscience
    Andrea Sattin, Chiara Nardin ... Tommaso Fellin
    Research Advance

    Two-photon (2P) fluorescence imaging through gradient index (GRIN) lens-based endoscopes is fundamental to investigate the functional properties of neural populations in deep brain circuits. However, GRIN lenses have intrinsic optical aberrations, which severely degrade their imaging performance. GRIN aberrations decrease the signal-to-noise ratio (SNR) and spatial resolution of fluorescence signals, especially in lateral portions of the field-of-view (FOV), leading to restricted FOV and smaller number of recorded neurons. This is especially relevant for GRIN lenses of several millimeters in length, which are needed to reach the deeper regions of the rodent brain. We have previously demonstrated a novel method to enlarge the FOV and improve the spatial resolution of 2P microendoscopes based on GRIN lenses of length <4.1 mm (Antonini et al., 2020). However, previously developed microendoscopes were too short to reach the most ventral regions of the mouse brain. In this study, we combined optical simulations with fabrication of aspherical polymer microlenses through three-dimensional (3D) microprinting to correct for optical aberrations in long (length >6 mm) GRIN lens-based microendoscopes (diameter, 500 µm). Long corrected microendoscopes had improved spatial resolution, enabling imaging in significantly enlarged FOVs. Moreover, using synthetic calcium data we showed that aberration correction enabled detection of cells with higher SNR of fluorescent signals and decreased cross-contamination between neurons. Finally, we applied long corrected microendoscopes to perform large-scale and high-precision recordings of calcium signals in populations of neurons in the olfactory cortex, a brain region laying approximately 5 mm from the brain surface, of awake head-fixed mice. Long corrected microendoscopes are powerful new tools enabling population imaging with unprecedented large FOV and high spatial resolution in the most ventral regions of the mouse brain.

    1. Neuroscience
    Takashi Yamamoto, Kayoko Ueji ... Shinya Ugawa
    Research Article

    The concept of ‘kokumi’, which refers to an enhanced and more delicious flavor of food, has recently generated considerable interest in food science. However, kokumi has not been well studied in gustatory physiology, and the underlying neuroscientific mechanisms remain largely unexplored. Our previous research demonstrated that ornithine (L-ornithine), which is abundant in shijimi clams, enhanced taste preferences in mice. The present study aimed to build on these findings and investigate the mechanisms responsible for kokumi in rats. In two-bottle preference tests, the addition of ornithine, at a low concentration that did not increase the favorability of this substance alone, enhanced the animals’ preferences for umami, sweet, fatty, salty, and bitter solutions, with the intake of monosodium glutamate showing the most significant increase. Additionally, a mixture of umami and ornithine synergistically induced significant responses in the chorda tympani nerve, which transmits taste information to the brain from the anterior part of the tongue. The observed preference enhancement and increase in taste-nerve response were abolished by antagonists of the G-protein-coupled receptor family C group 6 subtype A (GPRC6A). Furthermore, immunohistochemical analysis indicated that GPRC6A was expressed in a subset of type II taste cells in rat fungiform papillae. These results provide new insights into flavor-enhancement mechanisms, confirming that ornithine is a kokumi substance and GPRC6A is a novel kokumi receptor.